Properties (52)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
Psychologist
|
| gptkbp:advertising |
important for early detection
symptoms should be monitored |
| gptkbp:associated_with |
gptkb:dry_AMD
color vision changes visual hallucinations |
| gptkbp:causedBy |
vision loss
|
| gptkbp:characterDevelopment |
can lead to severe vision impairment
|
| gptkbp:clinicalTrials |
ongoing studies
new therapies |
| gptkbp:demographics |
more common in older adults
less_prevalent_in_African_Americans less_prevalent_in_Hispanics more_prevalent_in_Caucasians |
| gptkbp:diseaseResistance |
fluorescein angiography
optical coherence tomography (OCT) |
| gptkbp:frequency |
as needed injections
bi-monthly injections monthly injections |
| https://www.w3.org/2000/01/rdf-schema#label |
wet AMD
|
| gptkbp:impact |
independence
quality of life daily activities laser surgery photodynamic therapy anti-VEGF injections |
| gptkbp:influence |
increasing prevalence with aging population
leading cause of blindness in developed countries |
| gptkbp:is_monitored_by |
visual acuity tests
regular follow-ups with an eye doctor Amsler_grid_tests |
| gptkbp:outcome |
vision improvement
vision stabilization |
| gptkbp:research_focus |
gene therapy
new drug development |
| gptkbp:riskManagement |
age
obesity family history smoking |
| gptkbp:safetyFeatures |
healthy diet
quitting smoking regular eye exams |
| gptkbp:supports |
educational resources
patient support groups low vision rehabilitation |
| gptkbp:symptoms |
difficulty reading
dark or empty areas in vision difficulty recognizing faces distorted vision |
| gptkbp:technology |
understanding genetic factors
developing preventive strategies improving treatment efficacy |